Barrons.com
Seadrill, Vestis, Mastercraft Boat, and More Stocks See Action From Activist Investors
➖
AI Sentiment
Neutral
5/10
- Home
- IRON
IRON
Disc Medicine Inc.
as of 12-26-2025 3:45pm EST
$80.40
$0.03
-0.04%
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | WATERTOWN |
| Market Cap: | 3.4B | IPO Year: | N/A |
| Target Price: | $108.85 | AVG Volume (30 days): | 646.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.42 | EPS Growth: | N/A |
| 52 Week Low/High: | $30.82 - $99.50 | Next Earning Date: | 11-06-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered IRON Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 68.29%
68.29%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Disc Medicine Inc. (IRON)
Bitterman Kevin
Sell
Director
IRON Dec 17, 2025
Avg Cost/Share
$91.47
Shares
754
Total Value
$68,968.38
Owned After
349,210
Bitterman Kevin
Sell
Director
IRON Dec 16, 2025
Avg Cost/Share
$91.24
Shares
68,923
Total Value
$6,288,534.52
Owned After
349,210
Bitterman Kevin
Sell
Director
IRON Dec 15, 2025
Avg Cost/Share
$91.63
Shares
69,693
Total Value
$6,365,697.60
Owned After
349,210
Savage William Jacob
Sell
Chief Medical Officer
IRON Dec 15, 2025
Avg Cost/Share
$91.42
Shares
13,093
Total Value
$1,194,372.11
Owned After
85,153
Bitterman Kevin
Sell
Director
IRON Dec 12, 2025
Avg Cost/Share
$92.81
Shares
45,507
Total Value
$4,204,407.26
Owned After
349,210
Quisel John D
Sell
Chief Executive Officer
IRON Dec 11, 2025
Avg Cost/Share
$92.45
Shares
40,000
Total Value
$3,721,931.19
Owned After
209,409
Yu Jonathan Yen-Wen
Sell
Chief Operating Officer
IRON Nov 11, 2025
Avg Cost/Share
$84.59
Shares
30,000
Total Value
$2,540,922.64
Owned After
62,540
AI DMI LLC
Sell
10% Owner
IRON Oct 22, 2025
Avg Cost/Share
$80.47
Shares
744,047
Total Value
$59,873,462.09
Owned After
2,814,379
SEC Form 4
Bitterman Kevin
Sell
Director
IRON Oct 17, 2025
Avg Cost/Share
$88.51
Shares
70,000
Total Value
$6,223,933.59
Owned After
349,210
Bitterman Kevin
Sell
Director
IRON Oct 16, 2025
Avg Cost/Share
$77.11
Shares
1,425
Total Value
$109,881.75
Owned After
349,210
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Bitterman Kevin | IRON | Director | Dec 17, 2025 | Sell | $91.47 | 754 | $68,968.38 | 349,210 | |
| Bitterman Kevin | IRON | Director | Dec 16, 2025 | Sell | $91.24 | 68,923 | $6,288,534.52 | 349,210 | |
| Bitterman Kevin | IRON | Director | Dec 15, 2025 | Sell | $91.63 | 69,693 | $6,365,697.60 | 349,210 | |
| Savage William Jacob | IRON | Chief Medical Officer | Dec 15, 2025 | Sell | $91.42 | 13,093 | $1,194,372.11 | 85,153 | |
| Bitterman Kevin | IRON | Director | Dec 12, 2025 | Sell | $92.81 | 45,507 | $4,204,407.26 | 349,210 | |
| Quisel John D | IRON | Chief Executive Officer | Dec 11, 2025 | Sell | $92.45 | 40,000 | $3,721,931.19 | 209,409 | |
| Yu Jonathan Yen-Wen | IRON | Chief Operating Officer | Nov 11, 2025 | Sell | $84.59 | 30,000 | $2,540,922.64 | 62,540 | |
| AI DMI LLC | IRON | 10% Owner | Oct 22, 2025 | Sell | $80.47 | 744,047 | $59,873,462.09 | 2,814,379 | |
| Bitterman Kevin | IRON | Director | Oct 17, 2025 | Sell | $88.51 | 70,000 | $6,223,933.59 | 349,210 | |
| Bitterman Kevin | IRON | Director | Oct 16, 2025 | Sell | $77.11 | 1,425 | $109,881.75 | 349,210 |
Latest Disc Medicine Inc. News
IRON Breaking Stock News: Dive into IRON Ticker-Specific Updates for Smart Investing
Compare IRON vs Leading Stocks
See how IRON stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IRON Disc Medicine Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.